Sorrento Therapeutics Inc (SRNE)
0.015
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Sorrento Therapeutics Revenue (Quarterly): 15.02M for June 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 15.02M |
| March 31, 2023 | 16.25M |
| December 31, 2022 | 15.59M |
| September 30, 2022 | 17.40M |
| June 30, 2022 | 11.46M |
| March 31, 2022 | 18.38M |
| December 31, 2021 | 13.08M |
| September 30, 2021 | 12.06M |
| June 30, 2021 | 13.51M |
| March 31, 2021 | 14.26M |
| December 31, 2020 | 11.50M |
| September 30, 2020 | 11.75M |
| June 30, 2020 | 9.007M |
| March 31, 2020 | 7.721M |
| December 31, 2019 | 13.03M |
| September 30, 2019 | 5.778M |
| June 30, 2019 | 6.477M |
| March 31, 2019 | 6.143M |
| December 31, 2018 | 6.929M |
| September 30, 2018 | 4.105M |
| June 30, 2018 | 3.913M |
| March 31, 2018 | 6.246M |
| December 31, 2017 | 20.41M |
| September 30, 2017 | 121.91M |
| June 30, 2017 | 4.665M |
| Date | Value |
|---|---|
| March 31, 2017 | 4.874M |
| December 31, 2016 | 4.019M |
| September 30, 2016 | 2.243M |
| June 30, 2016 | 0.902M |
| March 31, 2016 | 0.988M |
| December 31, 2015 | 1.337M |
| September 30, 2015 | 1.103M |
| June 30, 2015 | 1.173M |
| March 31, 2015 | 0.977M |
| December 31, 2014 | 0.798M |
| September 30, 2014 | 1.276M |
| June 30, 2014 | 0.775M |
| March 31, 2014 | 0.976M |
| December 31, 2013 | 0.101M |
| September 30, 2013 | 0.083M |
| June 30, 2013 | 0.142M |
| March 31, 2013 | 0.134M |
| December 31, 2012 | 0.1222M |
| September 30, 2012 | 0.1345M |
| June 30, 2012 | 0.2171M |
| March 31, 2012 | 0.1101M |
| December 31, 2011 | 0.1279M |
| September 30, 2011 | 0.0918M |
| June 30, 2011 | 0.0742M |
| March 31, 2011 | 0.2354M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.778M
Minimum
Sep 2019
18.38M
Maximum
Mar 2022
12.49M
Average
13.03M
Median
Dec 2019
Revenue (Quarterly) Benchmarks
| Scilex Holding Co | 13.46M |
| AIM ImmunoTech Inc | 0.065M |
| Perspective Therapeutics Inc | -5.239M |
| Protalix BioTherapeutics Inc | 10.49M |
| Armata Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -95.21M |
| Total Expenses (Quarterly) | 91.79M |
| EPS Diluted (Quarterly) | -0.17 |
| Gross Profit Margin (Quarterly) | 43.74% |
| Profit Margin (Quarterly) | -633.7% |